Michaelson Jennifer

CIK 00018380611 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001838061

Recent Transactions

50 trades

Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2026-01-22$12.30/sh−4,000→ 128,635 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-12-19$10.01/sh−1,345→ 132,635 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-12-18$9.67/sh−2,898→ 133,980 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-12-15$11.90/sh−995→ 136,878 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-12-12$12.38/sh−2,148→ 137,873 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-11-24$12.30/sh−4,000→ 138,004 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-02-25$8.53/sh−3,756→ 142,004 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-02-19+50,000→ 145,760 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2025-02-19+100,000→ 100,000 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-01-06$12.51/sh−4,000→ 95,760 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-12-18$11.41/sh−4,693→ 99,760 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-12-12$12.52/sh−3,489→ 104,453 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-11-05$15.64/sh−8,000→ 107,942 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-09-05$18.09/sh−8,000→ 115,942 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-07-05$16.33/sh−8,000→ 123,942 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-07-01$9.00/sh+2,360→ 131,942 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2024-05-07−5,606→ 132,987 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-05-07$30.06/sh−5,606→ 129,582 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-05-07$4.30/sh+5,606→ 135,188 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2024-05-06−50,000→ 138,593 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-05-06$28.54/sh−20,277→ 129,582 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-05-06$4.30/sh+50,000→ 187,582 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-05-06$27.82/sh−37,723→ 149,859 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2024-02-22+100,000→ 100,000 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2024-02-22+50,000→ 137,582 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-12-21$8.50/sh−1,145→ 87,582 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-12-18$8.22/sh−238→ 88,727 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-12-12$7.81/sh−1,068→ 88,965 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-06-20$12.94/sh−238→ 90,033 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-06-12$13.11/sh−176→ 90,271 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-06-07$4.30/sh+100→ 90,547 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2023-06-07−100→ 188,593 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-06-07$12.40/sh−100→ 90,447 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-06-06$4.30/sh+11,900→ 102,347 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2023-06-06−11,900→ 188,693 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-06-06$12.31/sh−11,900→ 90,447 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-05-18$8.76/sh−239→ 90,447 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-05-12$8.78/sh−193→ 90,686 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-04-18$10.71/sh−238→ 90,879 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-04-12$10.22/sh−176→ 91,117 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-03-20$11.32/sh−238→ 91,293 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2023-02-17+77,000→ 77,000 total
Award
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2023-02-17+38,500→ 91,531 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2022-11-25$13.30/sh−4,000→ 53,031 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2022-11-25−4,000→ 200,593 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2022-11-25$4.30/sh+4,000→ 57,031 total
Sale
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2022-09-27$12.40/sh−4,000→ 53,031 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2022-09-27$4.30/sh+4,000→ 57,031 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2022-09-27−4,000→ 204,593 total
Exercise/Conversion
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2022-08-08−1,385→ 208,593 total

Companies

Cullinan Therapeutics, Inc.
Chief Scientific Officer
$CGEM

Recent Filings

Address

C/O CULLINAN THERAPEUTICS, INC. ONE MAIN STREET, SUITE 1350

CAMBRIDGE, MA, 02142

View on SEC.gov